Hartford Investment Management CO Meridian Bioscience Inc Transaction History

Hartford Investment Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 29, 2019	SELL	$15.51 - $17.61 $244,980 - $278,149	-15,795 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$14.85 - $16.35 $12,533 - $13,799	-844 Reduced 5.07%	15,795 $235,000
Q2 2018 Jul 19, 2018	BUY	$13.8 - $16.8 $229,618 - $279,535	16,639 New	16,639 $265,000
Q4 2017 Feb 12, 2018	SELL	$13.55 - $15.8 $157,180 - $183,280	-11,600 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$13.45 - $14.35 $156,020 - $166,460	11,600	11,600 $166,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Hartford Investment Management CO with notifications on news.